Selumetinib is currently FDA approved for children 2 years and older with symptomatic and inoperable plexiform neurofibromas.

CHICAGO -- Progression-free survival (PFS) in metastatic hormone receptor (HR)-positive breast cancer more than doubled with ...

The FDA launched a generative artificial intelligence tool designed to help employees, such as scientific reviewers and ...

"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

U.S. residents are recommended to get measles-mumps-rubella shots, anyway. But the CDC previously emphasized the importance of vaccination for travelers going to countries with outbreaks. Last week, ...

The acceptance and commitment therapy-based parenting program with asthma education, dubbed ACT-PAM, reduced unscheduled healthcare visits by a relative 67% compared with usual care -- a mean of 0.8 ...

"The potential harms of cannabis use in older adults are apparent, with increased risks of cardiovascular, respiratory, and ...

Healthcare groups and policy experts expressed concern about cuts included in the Trump administration's full budget proposal ...

Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the ...

CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

Dystrophin's isoforms are thought to contribute variably to neuropsychiatric disorders, behavioral disorders, and ...